Literature DB >> 24082312

Cognitive performances and mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder: results of a longitudinal follow-up study.

Michele Terzaghi1, Chiara Zucchella, Valter Rustioni, Elena Sinforiani, Raffaele Manni.   

Abstract

STUDY
OBJECTIVES: To investigate the capacity of neuropsychological deficits in idiopathic rapid eye movement sleep behavior disorder (iRBD) to predict the development of dementia and/or parkinsonism.
DESIGN: Prospective longitudinal follow-up study.
SETTING: Tertiary sleep center. PATIENTS: Twenty patients with initial iRBD (19 males, mean age 66.1 ± 7.1) underwent a clinical and neuropsychological follow-up within a mean of 43 ± 19 months. Neuropsychological performances at baseline were compared with those of healthy controls matched for sex, age, and education.
INTERVENTIONS: Discontinuation of clonazepam at least 7 days before the follow-up evaluation.
RESULTS: At follow-up, the Wilcoxon test showed a significant worsening of scores on Raven Colored Matrices 47 (P = 0.01), Attentive matrices (P = 0.002), phonemic (P = 0.04) and sematic (P = 0.04) fluency. Thirteen patients (65%) showed cognitive deterioration involving multiple domains. Of these, four patients (20%) maintained a stable cognitive dysfunction and nine (45%) showed a progression of cognitive dysfunction: six (30%) in constructional abilities (P = 0.03), four (20%) in short-term memory (P = NS), three (15%) in executive functions and non-verbal logic (P = NS), one (5%) in verbal fluency (P = NS), and one (5%) in long-term memory (P = NS) (McNemar test). Seven patients (35%) retained a normal cognitive profile. Mild cognitive impairment (MCI) was diagnosed at baseline in seven patients (35%). At follow-up, three of these patients showed overt dementia that was accompanied by parkinsonism in all cases; one had worsened from non-amnesic single-domain to nonamnesic multiple-domain MCI, two were stable, and one patient no longer met the criteria for MCI. Four patients (20%) without MCI at baseline had MCI at follow-up. Patients who developed MCI/dementia had an older age at disease onset (65.8 ± 5.4 versus 56.8 ± 9.3; P = 0.01) compared with those who did not.
CONCLUSIONS: Our findings corroborate evidence that visuospatial abilities constitute the area most affected in idiopathic rapid eye movement sleep behavior disorder (learning as a stable deficit and copying as an evolving deficit). Cognitive deterioration, involving mainly nonverbal logic, attention, and executive functions, can be observed in rapid eye movement sleep behavior disorder follow-up, suggesting an underlying evolving degenerative process. Our data confirm that mild cognitive impairment is frequent in idiopathic rapid eye movement sleep behavior disorder. The presence of mild cognitive impairment predicts the eventual risk of developing dementia, which seemed to be associated with parkinsonism.

Entities:  

Keywords:  Idiopathic REM sleep behavior disorder; neurodegenerative disorders; neuropsychological performances

Mesh:

Year:  2013        PMID: 24082312      PMCID: PMC3773202          DOI: 10.5665/sleep.3050

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  41 in total

Review 1.  REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP.

Authors:  Carlos H Schenck; Mark W Mahowald
Journal:  Sleep       Date:  2002-03-15       Impact factor: 5.849

2.  Impaired decision-making in idiopathic REM sleep behavior disorder.

Authors:  Taeko Sasai; Tomoyuki Miyamoto; Masayuki Miyamoto; Masaoki Iwanami; Takashi Abe; Masato Matsuura; Yuichi Inoue
Journal:  Sleep Med       Date:  2012-01-30       Impact factor: 3.492

3.  Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations.

Authors:  Tanis J Ferman; Bradley F Boeve; Glenn E Smith; Michael H Silber; John A Lucas; Neill R Graff-Radford; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Robert J Ivnik
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

4.  Decision making and executive functions in REM sleep behavior disorder.

Authors:  Margarete Delazer; Birgit Högl; Laura Zamarian; Johanna Wenter; Laura Ehrmann; Viola Gschliesser; Elisabeth Brandauer; Werner Poewe; Birgit Frauscher
Journal:  Sleep       Date:  2012-05-01       Impact factor: 5.849

5.  Symposium: Normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature.

Authors: 
Journal:  J Sleep Res       Date:  1993-12       Impact factor: 3.981

6.  Composite neuropsychological batteries and demographic correction: standardization based on equivalent scores, with a review of published data. The Italian Group for the Neuropsychological Study of Ageing.

Authors:  E Capitani; M Laiacona
Journal:  J Clin Exp Neuropsychol       Date:  1997-12       Impact factor: 2.475

7.  Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.

Authors:  Ronald B Postuma; Josie-Anne Bertrand; Jacques Montplaisir; Catherine Desjardins; Mélanie Vendette; Silvia Rios Romenets; Michel Panisset; Jean-François Gagnon
Journal:  Mov Disord       Date:  2012-02-09       Impact factor: 10.338

8.  REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.

Authors:  D O Claassen; K A Josephs; J E Ahlskog; M H Silber; M Tippmann-Peikert; B F Boeve
Journal:  Neurology       Date:  2010-07-28       Impact factor: 9.910

9.  Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.

Authors:  B F Boeve; M H Silber; J E Parisi; D W Dickson; T J Ferman; E E Benarroch; A M Schmeichel; G E Smith; R C Petersen; J E Ahlskog; J Y Matsumoto; D S Knopman; C H Schenck; M W Mahowald
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

10.  Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.

Authors:  Jean-François Gagnon; Mélanie Vendette; Ronald B Postuma; Catherine Desjardins; Jessica Massicotte-Marquez; Michel Panisset; Jacques Montplaisir
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

View more
  14 in total

Review 1.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

2.  Long-Term Follow-up Investigation of Isolated Rapid Eye Movement Sleep Without Atonia Without Rapid Eye Movement Sleep Behavior Disorder: A Pilot Study.

Authors:  Ambra Stefani; David Gabelia; Birgit Högl; Thomas Mitterling; Philipp Mahlknecht; Heike Stockner; Werner Poewe; Birgit Frauscher
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

Review 3.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

Review 4.  Clinical trials in REM sleep behavioural disorder: challenges and opportunities.

Authors:  Aleksandar Videnovic; Yo-El S Ju; Isabelle Arnulf; Valérie Cochen-De Cock; Birgit Högl; Dieter Kunz; Federica Provini; Pietro-Luca Ratti; Mya C Schiess; Carlos H Schenck; Claudia Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-05-13       Impact factor: 10.154

5.  Rapid Eye Movement Sleep Deprivation Induces Neuronal Apoptosis by Noradrenaline Acting on Alpha1 Adrenoceptor and by Triggering Mitochondrial Intrinsic Pathway.

Authors:  Bindu I Somarajan; Mudasir A Khanday; Birendra N Mallick
Journal:  Front Neurol       Date:  2016-03-07       Impact factor: 4.003

Review 6.  Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.

Authors:  Matej Skorvanek; Eva Feketeova; Monica M Kurtis; Jan Rusz; Karel Sonka
Journal:  Front Neurol       Date:  2018-05-25       Impact factor: 4.003

Review 7.  Relationships between Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: Clinical Assessments, Biomarkers, and Treatment.

Authors:  Min Li; Li Wang; Jiang-Hong Liu; Shu-Qin Zhan
Journal:  Chin Med J (Engl)       Date:  2018-04-20       Impact factor: 2.628

8.  Polysomnographic and neuropsychological characteristics of rapid eye movement sleep behavior disorder patients.

Authors:  Xuan Zhang; Zhiyi Song; Jingyi Ye; Ying Fu; Jinying Wang; Lei Su; Xiaodong Zhu; Meiyun Zhang; Yan Cheng; Wei Wu; Rong Xue
Journal:  Brain Behav       Date:  2019-02-14       Impact factor: 2.708

Review 9.  Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.

Authors:  Ane Murueta-Goyena; Ane Andikoetxea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

Review 10.  Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development.

Authors:  Poul Jennum; Julie Ae Christensen; Marielle Zoetmulder
Journal:  Nat Sci Sleep       Date:  2016-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.